CoChat

Speech and language markers of neurodegeneration: a call for global equity

Open access
García, Adolfo M, de Leon, Jessica, Tee, Boon Lead, Blasi, Damián E, Gorno-Tempini, Maria Luisa · 2023 · Brain

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index; 38 of the 138 sources its claims cite were checked for support.

Abstract

In the field of neurodegeneration, speech and language assessments are useful for diagnosing aphasic syndromes and for characterizing other disorders. As a complement to classic tests, scalable and low-cost digital tools can capture relevant anomalies automatically, potentially supporting the quest for globally equitable markers of brain health. However, this promise remains unfulfilled due to limited linguistic diversity in scientific works and clinical instruments. Here we argue for cross-linguistic research as a core strategy to counter this problem. First, we survey the contributions of linguistic assessments in the study of primary progressive aphasia and the three most prevalent neurodegenerative disorders worldwide—Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia. Second, we address two forms of linguistic unfairness in the literature: the neglect of most of the world’s 7000 languages and the preponderance of English-speaking cohorts. Third, we review studies showing that linguistic dysfunctions in a given disorder may vary depending on the patient’s language and that English speakers offer a suboptimal benchmark for other language groups. Finally, we highlight different approaches, tools and initiatives for cross-linguistic research, identifying core challenges for their deployment. Overall, we seek to inspire timely actions to counter a looming source of inequity in behavioural neurology.

Overview

CoChat Summary

## TL;DR

This paper is a perspective arguing that speech and language markers of neurodegeneration are promising but currently biased toward English and other high-income-language contexts. The authors call for cross-linguistic, cross-cultural research and shared tools to avoid turning “equitable” digital markers into a new source of global inequity.

## Key findings

  • Speech and language assessments are presented as useful for diagnosing and monitoring primary progressive aphasia, Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia, with automated speech and language analysis (ASLA) highlighted as scalable and low-cost.
  • The paper states that English is spoken to some proficiency by only 17% of the world’s population, yet dominates the literature; systematic reviews cited here report that speech/language studies span fewer than 20 languages overall, most in only a handful of papers.
  • Reported language-specific findings include:
  • In non-fluent/agrammatic PPA, English speakers showed more speech distortions, while Italian speakers showed distinct syntactic alterations.
  • In semantic variant PPA, surface dysgraphia is common in English-speaking patients but not in Chinese-speaking patients, whose errors are described as involving homophones.
  • In logopenic variant PPA, sentence repetition deficits were said to be more frequent in German than in English speakers.
  • In Alzheimer’s disease, language effects differed across English, French, Italian, Bengali, and Chinese cohorts, including differences in feature importance, subject omission, pronoun use, and reading impairment.
  • The authors note that some existing tools already span multiple languages, including the Comprehensive Aphasia Test in 13 languages, the Quick Aphasia Battery in 6 languages, and the Mini Linguistic State Examination validated in Spanish and Italian.

## Methods

  • Perspective/commentary article: the authors synthesize prior studies and reviews rather than reporting a new empirical sample.
  • The paper surveys evidence across primary progressive aphasia, Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia, emphasizing cross-linguistic comparisons.
  • The main analysis is a narrative review of published and emerging cross-linguistic tools, findings, and implementation challenges, illustrated with figures and tables summarizing language distribution and disorder-specific markers.

## Limitations

  • The paper itself notes that evidence is still limited, especially for behavioural variant frontotemporal dementia, for which it says no cross-linguistic studies have been performed to the authors’ knowledge.
  • It states that validated tools are unavailable for most languages, and that many existing tests rely on translations rather than true cultural/linguistic adaptation.
  • Evident from the text: this is a call for action rather than an original study, so its conclusions depend on the quality and scope of the cited literature rather than on new data collected here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/brain/awad253

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

20 Valid · 2 Not valid · 37 Not checked · 12 Own results and interpretations

26 more claims · 11 with their cited sources checked

Create a free account to see all 71 claims and to verify the 100 references still open.

See all claims — free account
  • It may state two separate claims as one. 31
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Citations

Cites

Cited by

See all 102

Metadata

Authors
García, A. M., de Leon, J., Tee, B. L., Blasi, D. E., & Gorno-Tempini, M. L.
Affiliations
  • Universidad de Santiago de Chile (CL)
  • Memory and Aging Center, Department of Neurology, University of California , San Francisco, CA 94143 , USA
  • University of California, San Francisco (US)
  • Harvard University (US)
Corresponding author
García, Adolfo M
Venue
Brain
Published
2023-07-27
Volume
146
Issue
12
Pages
4870-4879
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W4385295816
Cited by
102
References
144
Citations by year
2026: 43 · 2025: 32 · 2024: 22 · 2023: 5
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Global Brain Health Institute (GBHI ALZ UK-19-589585)
  • GBHI
  • Alzheimer’s Association, and Alzheimer’s Society (GBHI ALZ UK-22-865742)
  • FONDECYT Regular (1210176)
  • Universidad de Santiago de Chile (DICYT 032351GA_DAS)
  • Network of European Institutes for Advanced Study
  • Programa Interdisciplinario de Investigación Experimental en Comunicación y Cognición
  • USACH
  • Alzheimer’s Association and National Institutes of Health (NIDCD K23 DC018021)
  • Alzheimer’s Association (AACSFD-22-972143)
  • National Institutes of Health (NIA R21AG068757, NIA R56-AG069130, U01 NS128913, NINDS R01 NS050915, NIDCD K24 DC015544, NIA P01 AG019724, NIA U01 AG052943, UTA 17-000879, UG3 NS105557, R01 AG038791, R01 NS100440-01, R01AG058233, U01 AG045390, U54 NS092089)
  • Alzheimer’s Disease Research Center of California (P30 AG062422)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
Keywords
neurodegeneration, speech and language assessment, cross-linguistic research, linguistic diversity, primary progressive aphasia, Alzheimer's disease, Parkinson's disease, behavioral variant frontotemporal dementia
MeSH terms
Alzheimer Disease, Aphasia, Humans, Language, Linguistics, Speech

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.